Free Trial
Matthew Taylor

Matthew Taylor Analyst Performance

Managing Director at Jefferies Financial Group

Matthew Taylor is a stock analyst at Jefferies Financial Group in the medical sector, covering 17 publicly traded companies. Over the past year, Matthew Taylor has issued 15 stock ratings, including buy and hold recommendations. While full access to Matthew Taylor's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matthew Taylor's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
53 Last 11 Years
Buy Recommendations
60.38% 32 Buy Ratings
Companies Covered
17 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy60.4%32 ratings
Hold35.8%19 ratings
Sell3.8%2 ratings

Out of 53 total stock ratings issued by Matthew Taylor at Jefferies Financial Group, the majority (60.4%) have been Buy recommendations, followed by 35.8% Hold and 3.8% Sell.

Exchange Coverage

ExchangePercentageCount
NYSE
64.7% of companies on NYSE
11 companies
NASDAQ
35.3% of companies on NASDAQ
6 companies

Matthew Taylor, an analyst at Jefferies Financial Group, currently covers 17 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
17 companies
100.0%

Matthew Taylor of Jefferies Financial Group specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED PRODUCTS
12 companies
70.6%
MED INSTRUMENTS
3 companies
17.6%
MED/DENTAL - SUPP
1 company
5.9%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES
1 company
5.9%

Matthew Taylor's Ratings History at Jefferies Financial Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Boston Scientific Corporation stock logo
BSX
Boston Scientific
4/22/2026Lower Price Target$64.95$100.00Buy
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
3/17/2026Reiterated Rating$80.41$110.00Buy
Stryker Corporation stock logo
SYK
Stryker
3/4/2026Reiterated Rating$382.51$465.00Buy
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2/10/2026Lower Price Target$171.64$190.00Buy
Varex Imaging stock logo
VREX
Varex Imaging
2/2/2026Reiterated Rating$14.05$14.50Hold
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
12/11/2025Boost Price Target$85.38$105.00Buy
Insulet Corporation stock logo
PODD
Insulet
11/19/2025Upgrade$333.47$400.00Buy
Medtronic PLC stock logo
MDT
Medtronic
11/19/2025Reiterated Rating$100.83$110.00Hold
Insulet Corporation stock logo
PODD
Insulet
11/7/2025Boost Price Target$319.29$355.00Neutral
Insulet Corporation stock logo
PODD
Insulet
11/6/2025Boost Price Target$323.40$400.00Buy
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
10/29/2025Set Price Target$82.26$98.00Buy
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
10/29/2025Upgrade$82.73$98.00Buy
Abbott Laboratories stock logo
ABT
Abbott Laboratories
10/16/2025Boost Price Target$129.58$149.00Buy
Shoulder Innovations, Inc. stock logo
SI
Shoulder Innovations
8/25/2025Initiated Coverage$12.63$19.00Buy
Abbott Laboratories stock logo
ABT
Abbott Laboratories
7/18/2025Upgrade$120.76$145.00Buy
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4/17/2025Boost Price Target$129.74$137.00Hold
InMode Ltd. stock logo
INMD
InMode
4/14/2025Lower Price Target$15.05$15.00Hold